Efficacy of the BNT162b2 mRNA COVID-19 vaccine in a haemodialysis cohort
Nephrol Dial Transplant
.
2021 Aug 27;36(9):1756-1757.
doi: 10.1093/ndt/gfab165.
Authors
Luc Frantzen
1
,
Guilhem Cavaillé
1
,
Sandrine Thibeaut
2
,
Yohan El-Haik
3
Affiliations
1
Service de Néphrologie, Hôpital Saint Joseph Marseille, Marseille, France.
2
Laboratoire de Biologie Médicale, Hôpital Saint Joseph Marseille, Marseille, France.
3
Pharmacie, Centre de Dialyse DIAVERUM, Hôpital Saint Joseph Marseille, Marseille, France.
PMID:
34450646
PMCID:
PMC8135401
DOI:
10.1093/ndt/gfab165
No abstract available
MeSH terms
BNT162 Vaccine
COVID-19 Vaccines* / immunology
COVID-19* / prevention & control
Humans
Renal Dialysis*
Vaccines, Synthetic / immunology
mRNA Vaccines
Substances
COVID-19 Vaccines
Vaccines, Synthetic
BNT162 Vaccine